MAPT and Alzheimer disease: Their results suggested that R47H variant reduced phosphorylated tau and attenuated neurodegeneration in the PS19 mouse model of tauopathy.205 Recently, some advances on the molecular mechanism of TREM2 R47H mutation in affecting the development of AD have been reported,206–209 although the exact mechanism is still elusive.